Rising Applications Of Contrast Media Injectors In Neurosurgeries & Orthopedic Surgeries Is Expected To Drive Contrast Media Injectors Market Till 2025: Grand View Research, Inc.

The global contrast media injectors market is expected to reach USD 1.4 billion by 2025, growing at a CAGR of 5.8%, according to a new report by Grand View Research, Inc. Rising demand for minimally invasive surgical procedures is a major factor expected to boost the market during the forecast period. These devices assist surgeons in accurate insertion of contrast agents with reduced human errors, thus increasing the accuracy and efficiency of surgical procedures. They play a crucial role in Intraoperative Computed Tomography (iCT), Intraoperative Magnetic Resonance Imaging (iMRI), and interventional cardiology. Availability of advanced injector systems for diagnosis and intraoperative imaging has boosted adoption of these systems. For instance, Medrad Stellant CT injection system integrated with Certegra Workstation provides high efficiency and accuracy in CT imaging.

U.S. contrast media injectors market by product, 2014 - 2025 (USD million)


Technological advancements, such as automated contrast media injectors and double-head injectors, are also among major factors supporting the growth of the market. Automated contrast media injectors provide improved patient safety, accuracy, and enhance image quality. Also, double-head injectors allow a large and rapid initial bolus of contrast, which is required in several imaging procedures. For instance, in cardiac CT, a fast injection is required for imaging of both sides of the ventricular septum to identify septal thickness, shunts, and enlarged ventricles. Delivery of contrast media is more efficient and controlled with a dual-head injector.

Browse full research report on Contrast Media Injectors Market: www.grandviewresearch.com/industry-analysis/contrast-media-injectors                                       

Further key findings from the report suggest:

  • CT injector systems segment was the largest revenue-generating segment of the market in 2016 owing to availability of technologically advanced products and their widespread application for disease diagnosis and image-guided surgeries
  • The single head injectors segment accounted for the largest revenue share in 2016 and is expected to maintain its dominance throughout the study period
  • In the application segment, interventional cardiology is projected grow at the highest rate during the forecast period because of rising prevalence of cardiac diseases, such as coronary artery disease, heart valve disease, and peripheral vascular disease
  • In 2016, hospitals dominated the contrast media injectors market in terms of revenue because of an increase in the number of hospital admissions of patients suffering from cancer, neurological disorders, and cardiovascular diseases
  • The North America contrast media injectors market held the largest revenue share in 2016 and is projected to maintain its dominance during the forecast period owing to well-established healthcare infrastructure
  • Some of the major players are Bayer HealthCare LLC; Guerbet Group; Bracco Group; Medtron AG; GE Healthcare; Nemoto Kyorindo Co., Ltd.; Ulrich GmbH & Co. KG; VIVID IMAGING; Sino Medical-Device Technology Co., Ltd.; and APOLLO RT Co. Ltd.
Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/medical-devices          
                      
Grand View Research has segmented the global contrast media injectors market on the basis of product, type, application, end use, and region:

Product Outlook (Revenue, USD Million; 2014 - 2025)
  • Injector Systems
    • CT injector systems
    • MRI injector systems
    • Cardiovascular/angiography injector systems
  • Consumables
    • Tubing
    • Syringe
    • Others
Type Outlook (Revenue, USD Million; 2014 - 2025)
  • Single Head Injectors
  • Dual-Head Injectors
  • Syringeless Injectors
Application Outlook (Revenue, USD Million; 2014 - 2025)
  • Radiology
  • Interventional Cardiology
  • Interventional Radiology
End-Use Outlook (Revenue, USD Million; 2014 - 2025)
  • Hospitals
  • Diagnostics Centers
  • Ambulatory Surgery Centers
Regional Outlook (Revenue, USD Million; 2014 - 2025)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa
    • Saudi Arabia

                                                      
About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.


For more information: www.grandviewresearch.com

Comments

Popular posts from this blog

The global vein illuminator market is expected to reach USD 358.5 million by 2024, according to a new report published by Grand View Research, Inc. The vein illuminator market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors contributing towards the growth of the market are the growing aging population and the efforts channelized towards improving patient satisfaction. Additionally, factors, such as the demand for technologically advanced medical equipment and the rising research and practical applications are expected to be opportunistic for the industry growth. However, the prevalence of traditional methods owing to the high costs of the vein illuminator devices is likely to hinder the growth of the market in the near future. The vein illuminator market is segmented on the basis of technology, application, end-user, and region. Based on technology, the market is further categorized into transillumination, infrared technology, and ultrasound. The near-infrared illumination technology is estimated to be the largest shareholder due to its ability to penetrate deep into the tissue, which makes it possible to visualize the vessels clearly. On the basis of application, the market is segmented into intravenous access and blood draw. The end-user segment comprises hospitals, rehabilitation facilities, blood donation camps, and academic institutions. The market for hospitals is expected to grow rapidly during the forecast period due to a surge in the demand for technologically advanced medical equipment. The market is also categorized into North America, Europe, Asia Pacific, MEA, and Latin America. Browse full research report on global Vein Illuminator Market: http://www.grandviewresearch.com/industry-analysis/vein-illuminator-market Further key findings from the study suggest: • In terms of market share, the North America vein illuminator market is expected to hold majority of the share in 2016. Factors resulting in the growth of this industry are the steady preference for highly-advanced medical devices by hospitals as well as the presence of several medical device manufacturing companies in the region. • The infrared illumination technology is estimated to lead the industry due to its deep penetration capability into thick tissues tohighlight the presence of vessels with increased clarity. Based on application, the segment for intravenous access is estimated to be the largest shareholder, followed by the blood draw segment. • The vein illuminator industry comprises several local as well as global players. Some prominent players in this industry include Accuvein, Inc., Christie Medical Holdings, Inc., Infrared Imaging Systems, Inc., Translite, LLC, and Venoscope, LLC,among others. In order to hold a major share in the industry, the companies are adopting both organic as well as inorganic strategies. The major strategies adopted by the companies are new product development, mergers, collaborations, partnerships, geographical expansions, and acquisitions. • The companies are also focusing on research and development activities in order to enhance their product portfolio. For instance, in September 2015, Accuvein, Inc., declared its 26th patent, which was issued by the United States Patent and Trademark office for their vein visualization system. Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices Grand View Research has segmented the vein illuminator market on the basis of technology, application, and end-user application: Vein Illuminator Technology Outlook (Revenue, USD Million, 2013 - 2024) • Transillumination • Infrared technology • Others Vein Illuminator Application Outlook (Revenue, USD Million, 2013 - 2024) • Intravenous access • Blood draw • Others Vein Illuminator End-user Outlook (Revenue, USD Million, 2013 - 2024) • Hospitals • Blood donation camps • Academic institutions • Others Vein Illuminator Regional Outlook (Revenue, USD Million, 2013 - 2024) • North America • Europe • Asia Pacific • Latin America • MEA Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-vein-illuminator-market About Grand View Research Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc For more information: www.grandviewresearch.com

Hyaluronic Acid Market Is Likely To Be Influenced By The Increase In Obesity Till 2024: Grand View Research, Inc.

Protein Purification & Isolation Market Is Predicted To Grow Swiftly Due To Increased Research In The Fields Of Biotechnology & Pharmaceuticals Till 2025: Grand View Research, Inc.